DwightEarlHeronMDMBA, FACRO, FACR, FCTSI, FASTRO

Breast Cancer, Central Nervous System Cancer, Head & Neck

Enterprise Medical Director, Professor Radiation Oncology, Otolaryngology, Head & Neck Surgery Bon Secours Mercy Health President, American College of Radiation Oncology

Join to view full profile

Dr. Heron is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Heron's full profile

Already have an account?

Office
1044 Belmont Avenue
Youngstown, OH 44504
Phone+1 330-480-2182
Is this information wrong?

Summary

Dr. Heron is a proven visionary leader with >20-year track record of leading large integrated oncology programs through conception, development, implementation of innovative clinical programs, quality assurance, and practice acquisition and integration throughout the world. In this capacity, he has managed several hundred physicians including junior & mid-level faculty, resident physicians and medical students in the tradition of the biopsychosocial model. He has authored over 600 journal articles, book chapters, monographs and abstracts. He has also led several commercial entities including remote treatment planning and clinical pathways ensuring synergies in academics, clinical research, and business domains.

In his current role as Enterprise Medical Director for Oncology Services for Bon Secours Mercy Health, a 50-hospital comprehensive network, the 3rd largest in the United States, he coordinates teams of Medical, Radiation and Surgical Oncologists in delivering state-of-the-art oncology care across 8 states. As Professor of Radiation Oncology, Otolaryngology, Head & Neck Surgery, he has focused on pioneering re-irradiation strategies using SRS & SBRT for head & neck cancers, oligometastatic disease amongst others including the integration with immunotherapy

He received his medical degree from University of Rochester School of Medicine and Dentistry and has been in practice 22 years. He specializes in stereotactic Radiosurgery (intracranial & extra cranial), breast cancer, central nervous system cancer, and head & neck.

Education & Training

Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 1996 - 2000
NYU Long Island School of MedicineInternship, Internal Medicine, 1995 - 1996
University of Rochester School of Medicine and DentistryClass of 1995

Certifications & Licensure

OH State Medical License 2020 - 2026
FL State Medical License 2020 - 2025
NY State Medical License 2020 - 2025
CA State Medical License 2020 - 2024
WV State Medical License 2023 - 2024
PA State Medical License 1997 - 2024
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Fellow American Society of Radiation Oncology (FASTRO) American Society of Radiation Oncology (ASTRO), 2023
City's Best Doctors Pittsburgh Magazine, 2012-2020
Regional Top Doctor Castle Connolly, 2014-2017, 2019
Alpha Omega Alpha (AOA) Honor Society Alpha Omega Alpha, 2013
Best Doctors for Women Pittsburgh Magazine, 2012
Fellow of American College of Radiology (FACR) American College of Radiation Oncology, 2010
Fellow of American College of Radiation Oncology (FACRO) American College of Radiation Oncology, 2009
America's Leading Doctors Black Enterprise, 2008
2005 Exemplary Service Award in Medicine Omega Psi Phi Fraternity, 2005
Teacher of the Year Association of Residents in Radiation Oncology (ARRO), 2001-2002
Join now to see all

Clinical Trials

Radiation Therapy Outreach Program for Minority or Low-Income Patients With Newly Diagnosed Cancer Start of enrollment: 2004 Oct 01
Completed
Not Applicable
Patient Preference Survey for Radiation Oncologists Start of enrollment: 2006 Apr 01
Completed
Not Applicable
MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2005 Nov 11
Terminated
Phase 1, Phase 2
SBRT + TACE for Primary Hepatocellular Carcinoma Start of enrollment: 2009 Jul 01
Withdrawn
Not Applicable
Hypofractionated SBRT For Prostate Cancer Start of enrollment: 2010 Oct 07
Completed
Not Applicable
Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2007 Dec 26
Completed
Phase 2
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation Start of enrollment: 2013 Jun 07
Terminated
Phase 2
Radiosurgery for Patients Recurrent Oligometastatic Disease Start of enrollment: 2011 Jun 28
Completed
Not Applicable
SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma Start of enrollment: 2013 Feb 06
Completed
Not Applicable
Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma Start of enrollment: 2011 Jul 25
Completed
Phase 2
Stereotactic Body Radiation Therapy (SBRT) for Liver Mets Start of enrollment: 2012 Mar 23
Completed
Not Applicable
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Fractionated Stereotactic Radiosurgery for Large Brain Metastases Start of enrollment: 2013 Jul 16
Active, not recruiting
Not Applicable
SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN Start of enrollment: 2013 Jul 03
Completed
Phase 2
An Outcome Analysis for Stereotactic Body Radiation Therapy (SBRT) Treatment of Non-Small Lung Cancer Patients Using 4D PET/CT With Real-Time Position Management (RPM™) System and a Concomitant Evaluation of the Impact and Performance Characteristics of the Immobilization System Start of enrollment: 2011 Apr 01
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

3 citations
The Art of Radiation Therapy: The Necessary Risk of Radiation Necrosis for Durable Control of Brain Metastases.
Michael T Milano, Scott G Soltys, Lawrence B Marks, Dwight E Heron, Ellen Yorke, Jimm Grimm, Andrew Jackson, Alina Mihai, Robert D Timmerman, Jinyu Xue, Brian D Kavana...> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Feb 1
13 citations
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer.
Robert L Ferris, Jessica Moskovitz, Sheryl Kunning, Ayana T Ruffin, Carly Reeder, James Ohr, William E Gooding, Seungwon Kim, Brian J Karlovits, Dario A A Vignali, Uma...> ;Clinical Cancer Research. 2022 Apr 1
Validation of a New Clinical-Genetic Recursive Partitioning Analysis of High-Grade Glioma Using RTOG 0525, 0513 and 0131.
Philip A. Sutera, J.C. Flickinger, Hong Wang, Dwight E. Heron> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
Patient and Dosimetric Predictors of Genitourinary and Gastrointestinal Toxicity After Prostate SBRT: A Secondary Analysis of a Prospective, Multi-Institutional Phase ...
M.K. Abdelhakiem, Adam C. Olson, Beant S. Gill, Hong Wang, B. Davies, K. Holeva, David J. D'Ambrosio, Rodney E. Wegner, Dwight E. Heron> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
A Prospective, Single-Arm, Phase II, Multi-Center Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
Adam C. Olson, J.H. Skiba, Beant S. Gill, Hong Wang, B. Davies, K. Holeva, David J. D'Ambrosio, Rodney E. Wegner, Dwight E. Heron> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
9 citations
Late Toxicity and Long-Term Local Control in Patients With Ultra-Central Lung Tumours Treated by Intensity-Modulated Radiotherapy-Based Stereotactic Ablative Body Radi...
Alina Mihai, P.J. Armstrong, D. Hickey, Michael T. Milano, Mary Dunne, K. Healy, Pierre Thirion, D.E. Heron, N. Elbeltagi, John Armstrong> ;Clinical Oncology. 2021 Jun 4
20 citations
Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer
Anand Mahadevan, Shalini Moningi, Jimm Grimm, X. Allen Li, Kenneth M. Forster, Manisha Palta, Phillip Prior, Karyn A. Goodman, Amol Narang, D.E. Heron, Simon S. Lo, Ja...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 May 1
55 citations
Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases
Kristin J. Redmond, Chengcheng Gui, Stanley H Benedict, Michael T. Milano, Jimm Grimm, J. Austin Vargo, Scott G. Soltys, Ellen Yorke, Andrew Jackson, Issam El Naqa, La...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 May 1
9 citations
Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
Jimm Grimm, John A. Vargo, Panayiotis Mavroidis, Vitali Moiseenko, Bahman Emami, Sheena Jain, Jimmy J. Caudell, David A. Clump, Diane C. Ling, Shiva K. Das, Eduardo G....> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Feb 11
38 citations
A Multi-faceted Intervention Aimed at Black-White Disparities in the Treatment of Early Stage Cancers: The ACCURE Pragmatic Quality Improvement trial.
Samuel Cykert, Eugenia Eng, M. Manning, Linda Robertson, Dwight E. Heron, Nora S. Jones, Jennifer Schaal, Alexandra F. Lightfoot, Haibo Zhou, Christina Yongue, Ziya Gi...> ;Journal of the National Medical Association. 2020 Oct 1
1 citations
Radiation oncologists' attitudes and beliefs about intensity-modulated radiation therapy and stereotactic body radiation therapy for prostate cancer.
Bruce L. Jacobs, Megan Hamm, José G. Luiggi-Hernández, Dwight E. Heron, Jeremy M. Kahn, Amber E. Barnato> ;BMC Health Services Research. 2020 Aug 26
1 citations
Patterns of Failure After Adjuvant Stereotactic Body Radiation Therapy for Pancreatic Cancer With Close or Positive Margins.
Ankur K. Patel, Joshua L. Rodríguez-López, Nathan Bahary, Amer H. Zureikat, Steven A. Burton, Dwight E. Heron, Adam C. Olson> ;Advances in Radiation Oncology. 2020 Aug 26
3 citations
Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma.
Pattana Wangaryattawanich, Barton F. Branstetter, J.D. Ly, Umamaheswar Duvvuri, Dwight E. Heron, Tanya J. Rath> ;AJNR. American Journal of Neuroradiology. 2020 May 28
The Development and Validation of Prostate Cancer-specific Physician-Hospital Networks.
Bruce L. Jacobs, Jonathan G. Yabes, Samia H. Lopa, Dwight E. Heron, Chung-Chou H. Chang, Justin E. Bekelman, Joel B. Nelson, Julie P.W. Bynum, Amber E. Barnato, Jeremy...> ;Urology. 2020 Jan 13
4 citations
Assessment of deep inspiration breath hold technique setup reproducibility using mega voltage imaging for left breast cancer radiation therapy-integrated network study.
Hayeon Kim, M. Saiful Huq, Dwight E. Heron, Ron Lalonde, Christopher J. Houser, Colin E. Champ, Sushil Beriwal> ;Medical Dosimetry. 2020 Mar 1
1 citations
Increasing use of positron emission tomography among medicare beneficiaries undergoing radical cystectomy.
Avinash Maganty, Robert M. Turner, Jonathan G. Yabes, Dwight E. Heron, Jeffrey R. Gingrich, Benjamin Davies, Bruce L. Jacobs> ;European Journal of Cancer Care. 2020 Feb 5
2 citations
Long-Term Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy for Recurrent, Previously-Irradiated Head and Neck Cancer.
Joel Thomas, Hong Wang, David A. Clump, Robert L. Ferris, Umamaheswar Duvvuri, James Ohr, Dwight E. Heron> ;Frontiers in Oncology. 2020 Feb 5
Patterns of stereotactic body radiation therapy: The influence of lung cancer treatment on prostate cancer treatment.
Bruce L. Jacobs, Jonathan G. Yabes, Samia H. Lopa, Dwight E. Heron, Chung-Chou H. Chang, Justin E. Bekelman, Joel B. Nelson, Julie P.W. Bynum, Amber E. Barnato, Jeremy...> ;Urologic Oncology. 2020 Feb 1
1 citations
Dose-response model for severe late laryngeal toxicity after stereotactic body radiation therapy for previously-irradiated head and neck cancer.
Diane C. Ling, John A. Vargo, Rachel J Grimm, Brian J. Gebhardt, David A. Clump, Robert L. Ferris, James Ohr, Dwight E. Heron> ;Journal of Radiosurgery and SBRT. 2020 Jan 1
1 citations
The Influence of Stereotactic Body Radiation Therapy Adoption on Prostate Cancer Treatment Patterns
Bruce L. Jacobs, Jonathan G. Yabes, Samia H. Lopa, Dwight E. Heron, Chung-Chou H. Chang, Justin E. Bekelman, Joel B. Nelson, Julie P.W. Bynum, Amber E. Barnato, Jeremy...> ;The Journal of Urology. 2020 Jan 1
15 citations
Early clinical experience with varian halcyon V2 linear accelerator: Dual-isocenter IMRT planning and delivery with portal dosimetry for gynecological cancer treatments.
Hayeon Kim, M. Saiful Huq, Ron Lalonde, Christopher J. Houser, Sushil Beriwal, Dwight E. Heron> ;Journal of Applied Clinical Medical Physics. 2019 Nov 1
7 citations
Salvage Curative-Intent Reirradiation Stereotactic Body Radiation Therapy for Isolated Pelvic and/or Paraortic Recurrences of Gynecologic Malignancies
Diane C. Ling, John A. Vargo, Steven A. Burton, Dwight E. Heron, Sushil Beriwal> ;Practical Radiation Oncology. 2019 Nov 1
1 citations
Early Exploratory Analysis for Patient-reported Quality of Life and Dosimetric Correlates in Hypofractionated Stereotactic Body Radiation Therapy (SBRT) for Low-risk a...
Nick A. Iarrobino, Beant S. Gill, Philip A. Sutera, Ronny Kalash, David D’ Ambrosio, Dwight E. Heron> ;American Journal of Clinical Oncology. 2019 Nov 1
5 citations
Impact of postoperative radiation therapy for deeply invasive oral cavity cancer upstaged to stage III.
John D. Cramer, Sandeep Samant, Dwight E. Heron, Robert L. Ferris, Seugwon Kim> ;Head & Neck. 2019 May 1
1 citations
Correlation between real-time intraoperative and postoperative dosimetry and its implications on intraoperative planning
Chenyu Yan, M. Saiful Huq, Dwight E. Heron, Sushil Beriwal, Raymond B. Wynn> ;Brachytherapy. 2019 May 1
Join now to see all

Journal Articles

Utilizing Clinical Pathways and Web-Based Conferences to Improve Quality of Care in a Large Integrated Network Using Breast Cancer Radiation Therapy as the Model
Allison E Garda, Dwight E Heron, Scott M Glaser, Katherine S Chen, John A Vargo, Sushil Beriwal, BioMed Central

Other

A Dosimetric Evaluation of the IAEA‐AAPM TRS483 Code of Practice for Dosimetry of Small Static Fields Used in Conventional Linac Beams and Comparison with IAEA TRS‐398...
Dwight Heron, MD, Medical Physics
https://www.doximity.com/articles/486343da-d0ca-49a3-a7ea-1b492ed6ec73
UpToDate, Wolters Kluwer Health - 2012-08-15

Authored Content

A Dosimetric Evaluation of the IAEA‐AAPM TRS483 Code of Practice for Dosimetry of Small Static Fields Used in Conventional Linac Beams and Comparison with IAEA TRS‐398, AAPM TG51 and TG51 Addendum ProtocolsJuly 2018

Press Mentions

Specialized Doctor Brings New Technology to the Valley for Fighting Against CancerFebruary 24th, 2021
5 Things to Expect from External-Beam Radiation TherapySeptember 11th, 2018
Brainlab Raises Awareness About Radiosurgery for Brain Metastases Patients on World Cancer Day 2017February 3rd, 2017
Join now to see all

Grant Support

UPMC Mckeesport - Rocog II - Sustained Community Clinical Trial PhaseNational Cancer Institute2009–2010
UPMC Mckeesport/Rocog Radiation Oncology Minorities Outreach GroupNational Cancer Institute2007–2008
UPMC Mckeesport/Rocog Radiation Oncology Minorities Out*National Cancer Institute2003–2007